Thursday, January 25, 2024 1:34:35 PM
Recent CVKD News
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/04/2024 02:13:51 PM
- Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds • PR Newswire (US) • 11/02/2024 12:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 01:10:06 PM
- Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility • PR Newswire (US) • 10/24/2024 01:00:00 PM
- CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM • PR Newswire (US) • 10/23/2024 01:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/04/2024 08:15:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 08:05:31 PM
- Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference • PR Newswire (US) • 09/23/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 08:59:33 PM
- Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients • PR Newswire (US) • 08/22/2024 01:00:00 PM
- Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients • PR Newswire (US) • 08/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 10:03:04 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 10:03:22 AM
- Cadrenal Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 08/14/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:05:45 PM
- Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update • PR Newswire (US) • 08/07/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:02:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 01:10:15 PM
- Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs • PR Newswire (US) • 08/06/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 08:05:22 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/12/2024 08:10:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 06/11/2024 09:27:28 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/11/2024 09:25:39 PM
- Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients • PR Newswire (US) • 06/03/2024 01:00:00 PM
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM